- ►onlinejacc.org V Fuster, LE Ryden, RW Asinger, DS Cannom, … - Journal of the American College of Cardiology, 2001 - Elsevier The committee was composed of 8 members representing the ACC and AHA, 4
representing the ESC, 1 from the North American Society of Pacing and
Electrophysiology (NASPE), and a representative of the Johns Hopkins ... Cited by 1436 - Related articles - All 118 versions
- ►chestpubs.org MN Levine, G Raskob, RJ Beyth, C Kearon, … - Chest, 2004 - chestjournal.chestpubs.org This chapter about hemorrhagic complications of anticoagulant treatment is part
of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Bleeding is the major complication of ... Cited by 1078 - Related articles - BL Direct - All 14 versions
- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 888 - Related articles - BL Direct - All 21 versions
- ►onlinejacc.org V Fuster, LE Rydén, RW Asinger, DS Cannom, … - Journal of the American College of Cardiology, 2001 - Elsevier The American College of Cardiology (ACC) and the American Heart Association
(AHA) have jointly engaged in the production of such guidelines in the area of
cardiovascular disease since 1980. The ACC/AHA Task Force on Practice ... Cited by 453 - Related articles - BL Direct - All 10 versions
- ►hematologylibrary.org EA Sconce, TI Khan, HA Wynne, P Avery, L … - Blood, 2005 - bloodjournal.hematologylibrary.org Current dosing algorithms do not account for genetic and environmental factors
for warfarin dose determinations. This study investigated the contribution of
age, CYP2C9 and VKORC1 genotype, and body size to warfarin-dose ... Cited by 302 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org BF Gage, C van Walraven, L Pearce, RG Hart, … - Circulation, 2004 - Am Heart Assoc From the Division of General Medical Sciences, Washington University School of
Medicine, St. Louis, Mo (BFG); Departments of Medicine and of Epidemiology and
Community Medicine, University of Ottawa, and Ottawa Health Research ... Cited by 240 - Related articles - BL Direct - All 7 versions
C Kearon, SR Kahn, G Agnelli, S Goldhaber, … - Chest, 2008 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.08-0658 2008;133;454S-545S Chest Gary E. Raskob and
Anthony J. Comerota Clive Kearon, Susan R. Kahn, Giancarlo ... Cited by 211 - Related articles - All 16 versions
- ►hadassah.org.il [PDF] C Heneghan, P Alonso-Coello, JM Garcia- … - The Lancet, 2006 - Elsevier We identified 14 randomised trials of self-monitoring: pooled estimates showed
significant reductions in thromboembolic events (odds ratio 0·45, 95% CI
0·30–0·68), all-cause mortality (0·61, 0·38–0·98), and major ... Cited by 167 - Related articles - All 20 versions
- ►washington.edu [PDF] UI Schwarz, MD Ritchie, Y Bradford, C Li, … - New England Journal of Medicine, 2008 - content.nejm.org Results As compared with patients with the non-A/non-A haplotype, patients with
the A/A haplotype of VKORC1 had a decreased time to the first INR within the
therapeutic range (P=0.02) and to the first INR of more than 4 (P=0.003). ... Cited by 132 - Related articles - BL Direct - All 28 versions
- ►hematologylibrary.org EA Millican, PA Lenzini, PE Milligan, L … - Blood, 2007 - bloodjournal.hematologylibrary.org High variability in drug response and a narrow therapeutic index complicate
warfarin therapy initiation. No existing algorithm provides recommendations on
refining the initial warfarin dose based on genetic variables, clinical ... Cited by 86 - Related articles - BL Direct - All 7 versions
